

[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - WOPRAI
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - WOPRAI
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - WOPRAI
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - WOPRAI
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire
[ Fri, Sep 04th 2009
] - Market Wire

[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - WOPRAI
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - WOPRAI
[ Thu, Sep 03rd 2009
] - WOPRAI
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - WOPRAI
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
[ Thu, Sep 03rd 2009
] - Market Wire
Oncothyreon to present at Rodman &; Renshaw Global Healthcare Conference
SEATTLE, WA, Sept. 3 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX: ONY) announced today that Robert Kirkman, M.D., President and Chief Executive Officer, will present at the Rodman & Renshaw 11th Annual Healthcare Conference taking place Sept. 9-11, 2009 in New York. Dr. Kirkman will present at 2 p.m. Eastern Time on Thursday, Sept. 10. A live and archived webcast of the presentation will be accessible at[ http://www.wsw.com/webcast/rrshq15/onty ] or by visiting the Oncothyreon website[ www.oncothyreon.com ] under the "News & Events" section. About Oncothyreon Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit [ www.oncothyreon.com ].
For further information: Investor and Media Relations Contact: Julie Rathbun, Rathbun Communications, (206) 769-9219, [ ir@oncothyreon.com ]
Similar Health and Fitness Articles
[ Wed, Sep 02nd 2009
] - Market Wire
[ Thu, Aug 06th 2009
] - Market Wire
[ Tue, Aug 04th 2009
] - Market Wire
[ Mon, Aug 03rd 2009
] - Market Wire
[ Wed, Jul 29th 2009
] - Market Wire
[ Mon, Jun 15th 2009
] - Market Wire
[ Sat, May 30th 2009
] - Market Wire
[ Mon, May 18th 2009
] - Market Wire
[ Mon, May 18th 2009
] - Market Wire
[ Mon, Mar 23rd 2009
] - Market Wire